Papers - TOMITA Hirofumi
-
Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice.
Narita M, Hanada K, Kawamura Y, Ichikawa H, Sakai S, Yokono Y, Senoo M, Narita N, Shimada M, Osanai T, Okumura K, Tomita H
Hypertension research : official journal of the Japanese Society of Hypertension 2021.7
-
内科的治療で心嚢液の減少を認めた原発性乳糜心膜症の1例
酒井峻太郎, 西崎史恵, 芦立俊宗, 遠藤知秀, 澁谷修司, 花田賢二, 横山公章, 横田貴志, 山田雅大, 掛端伸也, 福田幾夫, 富田泰史
心臓 53 ( 7 ) 737 - 742 2021.7
-
Nintedanib-Induced Renal Thrombotic Microangiopathy.
Fujita T, Nakagawa H, Yokota T, Umetani J, Nagawa D, Nakata M, Narita-Kinjo I, Murakami R, Shimada M, Nakamura N, Tomita H
Case reports in nephrology and dialysis 11 ( 2 ) 227 - 232 2021.5
-
Double tachycardia with His-left ventricular and interventricular dissociations.
Itoh T, Kimura M, Tomita H
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2021.4
-
Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation.
Hagii J, Metoki N, Saito S, Shiroto H, Sasaki S, Takahashi K, Hitomi H, Baba Y, Yamada N, Seino S, Kamada T, Uchizawa T, Nakamura T, Yasujima M, Tomita H
Thrombosis journal 19 ( 1 ) 22 2021.3
-
Giant left atrial calcified myxoma-induced premature atrial contractions.
Shun Shikanai, Taihei Itoh, Hirofumi Tomita
23 ( 2 ) 183 - 183 2021.2
-
Giant left atrial calcified myxoma-induced premature atrial contractions.
Shikanai S, Itoh T, Tomita H
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 23 ( 2 ) 183 2021.2
-
Impact of gene polymorphisms in drug-metabolizing enzymes and transporters on trough concentrations of rivaroxaban in patients with atrial fibrillation.
Junichi Nakagawa, Takahiko Kinjo, Mei Iizuka, Kayo Ueno, Hirofumi Tomita, Takenori Niioka
128 ( 2 ) 297 - 304 2021.2
-
Impact of gene polymorphisms in drug-metabolizing enzymes and transporters on trough concentrations of rivaroxaban in patients with atrial fibrillation.
Nakagawa J, Kinjo T, Iizuka M, Ueno K, Tomita H, Niioka T
Basic & clinical pharmacology & toxicology 128 ( 2 ) 297 - 304 2021.2
-
Towards Further Development of a Quality Improvement System for Stroke Practice in Japan.
Hirofumi Tomita
Circulation journal : official journal of the Japanese Circulation Society 85 ( 2 ) 210 - 212 2021.1
-
Towards Further Development of a Quality Improvement System for Stroke Practice in Japan.
Tomita H
Circulation journal : official journal of the Japanese Circulation Society 85 ( 2 ) 210 - 212 2021.1
-
Clinical impact of complete atrioventricular block in patients with ST-segment elevation myocardial infarction.
Yosuke Kawamura, Hiroaki Yokoyama, Kazutaka Kitayama, Naotake Miura, Misato Hamadate, Daiki Nagawa, Masashi Nozaka, Masamichi Nakata, Fumie Nishizaki, Kenji Hanada, Takashi Yokota, Masahiro Yamada, Takumi Higuma, Hirofumi Tomita
Clinical cardiology 44 ( 1 ) 91 - 99 2021.1
-
PolyIC Induces Retinoic Acid-inducible Gene-I and Melanoma Differentiation-associated Gene 5 and Modulates Inflammation in Podocytes.
Masamichi Nakata, Michiko Shimada, Ikuyo Narita-Kinjo, Daiki Nagawa, Kazutaka Kitayama, Misato Hamadate, Naotake Miura, Masashi Nozaka, Yosuke Kawamura, Takeshi Fujita, Reiichi Murakami, Tadaatsu Imaizumi, Norio Nakamura, Hirofumi Tomita
In vivo (Athens, Greece) 35 ( 1 ) 147 - 153 2021.1
-
PolyIC Induces Retinoic Acid-inducible Gene-I and Melanoma Differentiation-associated Gene 5 and Modulates Inflammation in Podocytes.
Nakata M, Shimada M, Narita-Kinjo I, Nagawa D, Kitayama K, Hamadate M, Miura N, Nozaka M, Kawamura Y, Fujita T, Murakami R, Imaizumi T, Nakamura N, Tomita H
In vivo (Athens, Greece) 35 ( 1 ) 147 - 153 2021.1
-
Clinical impact of complete atrioventricular block in patients with ST-segment elevation myocardial infarction.
Kawamura Y, Yokoyama H, Kitayama K, Miura N, Hamadate M, Nagawa D, Nozaka M, Nakata M, Nishizaki F, Hanada K, Yokota T, Yamada M, Higuma T, Tomita H
Clinical cardiology 44 ( 1 ) 91 - 99 2021.1
-
Clinical Therapy in Patients with Aborted Sudden Cardiac Death due to Coronary Spasm
Sueda Shozo, Yamamoto Katsuhito, Iwasaki Yoshihiro, Yoshida Ritsu, Nakamura Shigeru, Ogino Yutaka, Kimura Kazuo, Sasai Masahiro, Suzuki Hiroshi, Wakatsuki Tetsuzo, Asajima Hiroshi, Shinohara Tetsuji, Teragawa Hiroki, Ishikawa Tetsunori, Kitamura Kazuo, Oda Tsuyoshi, Nakayama Takashi, Kobayashi Yoshio, Sunada Daiki, Yamaki Masaru, Nishizaki Fumie, Tomita Hirofumi, Takahashi Naohiko, Usuda Kazuo, Fujinaga Hiroyuki, Kuramitsu Shoichi, Ando Kenji, Kiyooka Takahiko, Kadota Kazushige, Ishii Yoshinao, Ohtani Hayato, Maekawa Yuichiro, Taguchi Eiji, Shite Junya, Nakao Koichi, Kobayashi Nobuaki, Seino Yoshihiko, Nakagawa Hitoshi, Saito Yoshihiko, Komuro Issei, Sasaki Yasuhiro, Ikeda Shuntaro, Yamaguchi Osamu, Kakutani Akiyoshi, Shoji Toshihiro, Imanaka Takahiro, Ishihara Masaharu, Ishii Masanobu, Kaikita Koichi, Tsujita Kenichi, Akao Masaharu, Kijima Yoshiyuki, Masuyama Tohru, Miyaji Tsuyoshi
Journal of Coronary Artery Disease 26 ( 4 ) 91 - 99 2020.12
-
Decreased cardiac pacemaking and attenuated β-adrenergic response in TRIC-A knockout mice.
Manabu Murakami, Yuichi Toyama, Manabu Yonekura, Takayoshi Ohba, Yasushi Matsuzaki, Daisuke Sawamura, Agnieszka M Murakami, Miyuki Nishi, Shirou Itagaki, Hirofumi Tomita, Hiroshi Takeshima
PloS one 15 ( 12 ) e0244254 - e0244254 2020.12
-
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design.
Shinya Fujiki, Kenichi Iijima, Masaaki Okabe, Shinichi Niwano, Kenichi Tsujita, Shigeto Naito, Kenji Ando, Kengo Kusano, Ritsushi Kato, Junichi Nitta, Tetsuji Miura, Takeshi Mitsuhashi, Kazuomi Kario, Yusuke Kondo, Masaki Ieda, Nobuhisa Hagiwara, Toyoaki Murohara, Kazuyoshi Takahashi, Hirofumi Tomita, Yasuchika Takeishi, Toshihisa Anzai, Wataru Shimizu, Masafumi Watanabe, Yoshihiro Morino, Takeshi Kato, Hiroshi Tada, Yoshihisa Nakagawa, Masafumi Yano, Koji Maemura, Takeshi Kimura, Hisako Yoshida, Keiko Ota, Takahiro Tanaka, Nobutaka Kitamura, Koichi Node, Yoshifusa Aizawa, Ippei Shimizu, Daisuke Izumi, Kazuyuki Ozaki, Tohru Minamino,
Diabetes therapy : research, treatment and education of diabetes and related disorders 11 ( 11 ) 2739 - 2755 2020.11
-
Clinical Outcomes of Acute Myocardial Infarction Patients With a History of Malignant Tumor.
Masashi Nozaka, Hiroaki Yokoyama, Kazutaka Kitayama, Daiki Nagawa, Misato Hamadate, Naotake Miura, Yosuke Kawamura, Masamichi Nakata, Fumie Nishizaki, Kenji Hanada, Takashi Yokota, Masahiro Yamada, Hirofumi Tomita
In vivo (Athens, Greece) 34 ( 6 ) 3589 - 3595 2020.11
-
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design.
Fujiki S, Iijima K, Okabe M, Niwano S, Tsujita K, Naito S, Ando K, Kusano K, Kato R, Nitta J, Miura T, Mitsuhashi T, Kario K, Kondo Y, Ieda M, Hagiwara N, Murohara T, Takahashi K, Tomita H, Takeishi Y, Anzai T, Shimizu W, Watanabe M, Morino Y, Kato T, Tada H, Nakagawa Y, Yano M, Maemura K, Kimura T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Aizawa Y, Shimizu I, Izumi D, Ozaki K, Minamino T, EMPA-ICD investigators.
Diabetes therapy : research, treatment and education of diabetes and related disorders 11 ( 11 ) 2739 - 2755 2020.11